<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 77 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page76.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=77">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 77 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 77</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=77"><img src="../thumb/77.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>46 / 2020-04                                                         Central Nervous System - 1.8
   Contraindications: Pregn.    Special precautions: May mask sympt.of other agents overdos./  trapyramid. reacts., concom.other centr.act. agents, hypertens.cris.in
   Side effects: CNS eff., hypotens., musc.weakn. & inco-ordinat.,   GI obstruct., childr., eldery & debilit. pts., imp.liv./kidn./CV/cerebro-  pts.with phaeocromocytoma, epilep., Parkinson’s dis., depress. hist.
   GI disturbs., diffic.micturit., dry mouth, tight chest, tingl., heavin.&   vasc./resp. funct., clos.angle glauc., Parkinson., diab.mellit., hypothy-  Drug interactions: Incr.toxic.with Li, dimin. absorpt. of drugs from
   weakn.of hands, fix.drug erupt., general.chorea, hypersens. hepatit.,   roid., myasthen.grav., prostat.hypertrophy, epilep., regul.eye exam./  stomach & enhanc.absorpt. from small intest., poss.prolong.suxam-
   cerebr.stimul.in childr., large dos.may precipit.fits in epilept., allergy,   monit.haematol.paramet. advis. dur.longt.ther., withdr.grad., cont.lact.  ethon. induc. neuromusc.block., prolact.bld.conc.incr., neurotoxic.
   anaphylax., bld. dyscras., masks warn.signs of ototox.drug damage.  Drug interactions: Eff.of CNS depress.enhanc., sev. hypotens.eff.  with carbamazepine, ac.anx./rigid./ gen. trem./opisthoton./hyper-
   Special precautions: Glauc., prostat. hypertrophy.  with other hypotensiv., reduc. anti-hypertens.act.of guanethidine/  tens.potent.with hydroxyzine.
   Drug interactions: Enhanc.sedat.eff.of CNS depress.incl.alcoh.,   other adrenerg. neurone blocks., adverse effs.of antimuscarin. po-  SIBELIUM, Janssen Pharmaceutica (Pty) Ltd.
   eff.of atrop.& TCA’s enhanc.  tent., incr.neurolept.-induc.extrapyramid.eff.risk with metoclopra-
                                mide, incr. ventric.arrhythm.with antiarrythm.which prolong QT interv.  See Section 1.9
   MENIVERT, (Aspen Pharmacare) Pharmacare [P/S]              STEMETIL, Sanofi-Aventis [P/S]
   Betahistine dihydrochlor.    MOTILIUM, Janssen Pharmaceutica [P/S]
   Indications: Vertigo assoc.with Ménière’s syndr.  Domperidone.  Prochlorperazine.
                                                              Indications: N&V assoc.with migraine, vertigo due to Ménière’s
   (S3) TABS. 46/5.6/0960       Indications: Short-term treatm.of delay.gastr. empty.of funct.ori-
   723921-001: 24 mg, 20, R237,17  gin with gastro-oesophag. reflux &/dyspeps., N&V of centr./loc.  dis./labyrinth dysfunct., schizophren., mania & other psychoses
                                                              (S5) TABS, [P/S] B518.
   Dosage:  Adults: 24-48 mg dly.in div.dos. One 24 mg tab. twice dly.   orig./aft.cytostat.& radiat.ther., facilit.upper GIT radiologic.examinat.  766542-009: 5 mg, 25, R97,57
   Indiv.accord.to respon.      (S4) SUSP, [P/S] V/5.7.2/19. 1 mg/ml  (S5) SUPPS, [P/S] B522,523.
   Contraindications: Phaeochromocytoma.,  799807-028: 100 ml, R75,66  766518-019: 5 mg, 5, R82,78
   Side effects: Hypersens.reacts., headache, head press., occas.  Dosage: Admin.15-30 mins.bef.meals. Adults/adolesc. ≥12 yrs. &   766526-003: 25 mg, 5, R105,10
   drowsin., palpitat., tight chest, pre-exist. bronch.asthma exacerbat.,   childr.weigh. ≥35 kg: Admin.low.effect. dos.(typic.30 mg/day). Indiv.   (S5) INJ, [P/S] B524. 12,5 mg/ml.
   naus., dyspeps., retch., heartburn, gastric discomf., pain, flatul., cu-  10 ml 3-4xdly. May be incr.if necess.to max.dly. dos.of 40 mg(40 ml   766461-009: 10x1 ml amps, R178,59
   tan. hypersens.reacts.partic.angioneurot.oed., urticar., rash, prurit.  of 1 mg/ml susp.). Max.durat: not exceed.1 wk. for ac.N&V. Other in-  Dosage: N&V Prevent: 5-10 mg 2-3x/day. Treatm: 20 mg orally, or
   Warnings and special precautions: Pept.ulc. /hist., bronch.asth-  dic: Init.durat.up to 4 wks. Pt. to be re-eval.if treatm. exceeds 4 wks.  12,5 mg by deep IMI, or 25 mg as supps.with further doses orally.
   ma, urticar., rashes, allerg. rhinit., sev.hypotens., porphyr., if admin.  Infts./childr.&lt;12 yrs/adults & adolesc.weigh. &lt;35 kg: Admin.  Vertigo & Ménières dis: 15-30 mg/day in div. dos.grad.reduc.aft.
   subseq.to antihistam. poss.withdr.sympts.if antihistam. treatm. sudd.  low.effect.dos. 0,25 mg/kg 3-4xdly. Max.dly.dos: 35 mg/day (1 mg/  sev.wks.to 5-10 mg/day.
   withdrawn, avoid concom.antihist., diabet., concom.MAOI incl.MAO-  kg but no more than 35 ml). Dos. to be determin.accurat. based on   Psychoses: 12,5 mg orally 2x/day x7 days adjust. grad.to 75-100 mg
   B select., safety in pregn.& lactat.not est., childr.& adolesc.und.18 yrs.   bm. Do not exceed recomm.max.indiv. dly.dos.in neonat./infts./tod-  dly.accord.to respons. with some pts being maint.on 25-50 mg/day or
   due to lack of safety & effic.data, lact.intol.  dl.& childr. Usual.max. durat: Not exceed. 1 wk for ac. N&V. Other   25 mg 2-3xdly may be given rectally or 12,5-25 mg 2-3xdly by deep
   Interactions: Metabol.poss.inhibit.by meds. inhibit.MAO incl.  indic: Init. treatm.durat: up to 4 wks. Pts.to be re-eval.& need for   IMI. High.dos.given for psychos.
   MAO subtype B                cont. treatm.re-assess.       Childr: Owing to the risk of sev.extrapyramid. reacts.the follow.oral/
   METOCLOPRAMIDE 10 OETHMAAN,   (S4) TABS, [P/S] K/5.7.2/261.  rect.dosages are suggest: 10-13 kg: up to 7,5 mg/day. 14-17 kg: up
                                744611-105: 10 mg, 10, R100,37
   Oethmaan Biosims [P/S]       744611-016: 10 mg, 100, R1 003,90  to 10 mg/day. 18-39 kg: up to 15 mg/day.
   Metoclopramide HCl           Dosage: Admin. 15-30 mins.bef.meals. Indiv. Low.effect dos.  Contraindications: Pre-exist.CNS depress., coma, bone-marrow
   Indications: Gastr.stasis/hypomotil., postvagot. syndr., N&V in GI   Adults & adolesc.over 12 yrs.weigh. 35 kg or more: 1 tabs.3-  suppress., phaeochromocyt., imp.liv./kidn./CV, cerebrovasc.& resp.
   disords./drug induc.N&V, uraem. condits./malign.dis./post.anaesth.  4xdly. Max.dly.dos: 40 mg. Not suit. for childr.weigh.&lt;35 kg. Max.du-  funct., clos. angl.glauc., parkinsonism, diab.mellit. hypothyroid.,
   vomit., speeds gastr.empty.& dilat.duod.bulb esp.in cases where   rat: Not exceed.1 wk. for ac. N&V. Other indic: Init.durat.up to 4 wks.   myasthen.grav., untreat.epilep., prostat.hypertrophy, not recomm.in
   Ba meal studies delay.by duod.cap spasm/facilit. hypoton.stomach   Pts.to be re-eval.& need for cont. treatm. re-assess.  childr. weigh. &lt;10 kg., concom.admin.with agents know to cause QT
   exam.with delay.empty./Ba N&V prev.or contr.in Ba meal exam., aid   Contraindications: Prolact.-releas.pituit.tumour, concom.keto-  prolongat., safety in pregn.& lactat.not est.
   to GI intubat. proced.       conazole/erythromycin/other CYP3A4 inhibits.which prolong QT   Side effects: QT-interv.prolongat.& potent.fatal onset of ser.ventric.
   (S4) TABS. Q/5.7.2/228       interv., co-admin.with meds. known to induc.Torsades de Pointes   arrhythm.of torsade de pointes type, sudd.death from poss.card. ar-
   757845-010: 10 mg, 100, R26,88  &/ prolong QT interv., hypokalaem., hypomagnesaem., bradycard./  rhythm./ aspirat. & asphyx.due to suppress.of cough & gag reflex,
   Dosage: Admin.3xdly. Adults & childr.over 14 yrs: 10 mg. Childr.   heart block, pre-exist.card.dis., sev.ren. impairm., known congenit.  antimuscarin.effs., dry mouth, constipat., paralyt. ileus, micturit.diffic.,
   5-14 yrs: 5 mg. Childr. 3-5 yrs: 2,5 mg.  long QT interv./family hist thereof., mod./sev.hepat.impairm., safety   eye disords., blurr.vis., mydrias., miosis, pigment deposit.in skin & eyes
   Contraindications: Susp./confirm. phaeochromocyt.  in pregn. & lactat.not est., GI condits.advers.affect. by gastr.motil.  follow.prolong use, tachycard., card.arrhythm., hypotens., delirium,
   Side effects: Less freq: Neurolept.malign.syndr. in which case   stimulat., similtan.antacids/anti-secret.agents, Tabs.also: lact.intol.,   agitat., cataton.-like states, insomn., depress., EEG chang., convuls.,
   ther.to be discont./appropr.treatm. init. if sympt.pres., sev.allerg.re-  Susp.also: sorbitol intol.  extrapyramid. dysfunct., neurolept.malign.syndr., nas.congest., min.
   acts., bld.dyscras., card. disords.incl.superventric.tachycard., trans.   Side-effects: Depress., anx., loss./decr.libido, headache, somnol.,   liv.funct.test abnorm., ejaculat. inhib., impot., priapism, amenorrh.,
   plasma aldoster.conc.incr.result. in oed.in pts.with CHF, CNS effs.,   akathis., diarrh., hypersens., skin reacts., gynaecomast., breast ten-  galactorrh., gynaecomast., hypersens.reacts., syndr.resembl. SLE,
   extrapyramid.dyston.-like reacts. incl.spasm of facial &/extra-ocul.  dern./ enlargem./ pain/swell./disch., galactorrh., amenorrh., irreg.  photosens., jaund., bld.dyscras., imp.body temp.regulat loc. reacts.,
   musc/ trismus/ bulb. speech type/unnatur.head & should. posit.,   menstruat., lactat.disord., asthen., dry mouth, anaphylact.react.incl.  pain, depend., alt. endocr. & metabol. functs., weight gain, hyper-
   incr. musc.tone, dizzin., faintn., agitat., anx., aggress., tard.dyskines.,   shock, psych. disords., CNS effs.incl.dizzin., extrapyramid.disord. prim.  glycaem., alt.gluc.toler.
   GI disords., lassit., breast engorgem., skin rash.  in infts.& childr., convuls., incr.ser.ventric. dysrhythm./ sudd.card.death   Special precautions: Exacerbat.QT prolongat. in pres.of brady-
   Warnings and special precautions: Tard. dyskines. somet.irrevers.   risk poss.high.in pts. old.than 60 yrs./oral dos.&gt; 30 mg/day, angioed.,   card./hypokalaem./congenit./ acquir. QT prolongat., seiz.thresh.low.
   most.in elderly women, risk of develop.syndr./probabil.becom.irrevers.   urin. retent., abnorm.liv.funct.test.  in epilept. receiv. anticonvuls., childr.partic.&lt;10 kg bm as sev.dyston.
   poss. incr.with treatm.durat.& tot.cumulat.dos., discont. ther.if S&S   Warnings and special precautions: Excret.in breast milk., sev.  reacts. have follow.use, elderly, depend.type withdr.sympts.follow.
   of tard.dysines.devel., avoid prolong. treatm.unless benef.outweighs   ren.impairm., concom. potent CYP 3A4 inhibits. not known to cause   abrupt withdr., effs.on the vomit centre may mask sympts of OD
   tard. dyskines risk, other concom.central.act.agents, signif. ren./hepat.  QT-interv. prolong./ meds.caus.QT-interv.prolong., concom. antacids/  from other agents/ disords.such as GI obstruct., admin.at extrem.
   impairm., incr.extrapyramid. reacts. risk in childr./young adults/elderly,   antisecret.agents to be admin.aft.meals, elderly, adher.to dos.in neo-  of temp.hazard., reg.eye examinat., avoid.of undue expos.to direct.
   reg. eval. dur.prolong.ther., epilep., asthma, lact.intol., Parkinson’s dis.,   nat./toddl.& young childr.as neurol.S/E risk high.where metab.funct.&   sunlight recomm., monit. haematologic.paramet.periodic., withold
   depress./porphyr.hist., concom. phenothiaz., consid.unsafe dur.pregn.  bld.brain barrier not fully devel.  in labour until cervix dilat.3-4 cm.as labour may be prolong., admin.
   as teratogen. in anim.stud., benef.vs.risk in lactat., not to be used for   Drug interactions: CYP3A4 enzyme inhib. incr. plasma lev., antac-  of meds.with similar act.
   symptom.contr.of TD/when musc. contract.stimulat. poss.aff.GI con-  ids & antisecret.agents low. oral bioavailabil., anticholinerg.compds.  Drug interactions: Sympts.of CNS depress. enhanc.by other CNS
   dits.as in GI haemorrh./ obstruct./perforat./for few days aft.surg., sup-  poss. antagon. anti-dyspept. eff., absorpt.of other medic.poss. affect.,   depress.incl.alcoh, reduc. antihypertens.act.of guanethid & other
   press.of tard.dyskines.signs theref. mask.underly.dis.  absorpt.imp.by reduc.gastr.acidity, oral bioavailabil.reduc.by prior ci-  adrenerg. neurone block., poss.potent.of other antimuscarin., me-
   Interactions: Poss.interfer.with meds.with a hypoprolactinaem. eff.  metidine /sod. bicarbon., interfer.with ser.prolact. lev.& poss. other   toclopramide may incr.risk of neurolept.induc. extrapyramid.eff.,
   eg. bromocriptine, extrapyramid. reacts.poss.precipit.with phenothia-  hypoprolactinaem.agents., periph.eff.of dopaminerg. agon.suppress.  antiarrhythm.which prolong the QT-interv.may incr.likelikhood of
                                                              ventric.arrhythm.
   zin., incr. Li-toxic., incr.CNS depress.eff., GI eff.antagon.with opioids/
   antimuscar., caut. advis.with other centr.act.meds.eg. anti-epilept.,   MYLAN GRANISETRON, Mylan (Pty) Ltd  STUGERON, Janssen Pharmaceutica [P/S]
   may dimin.absorpt.from stomach/enhanc.small intest.absorpt.  See Section 6.2  Cinnarizine.
   eg.alcoh./cyclosp./ levodopa/aspir./ paracet., inhib.ser.cholinester-  Indications: Vestib.sympts of periph.& centr. origin, labyrinthine dis-
   ase & poss.prolong suxamethonium.neuromusc.block.  PHARMA-Q METOCLOPRAMIDE INJECTION 10 mg/2 ml,   ords., mot.sickn.prophylax., adjunct in periph arter.dis.
                                Pharma-Q [P/S]
   MITIL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  Metoclopramide HCl  (S2) TABS, C/5.7/590.
                                                              767123-018: 25 mg, 10, R54,62
   Prochlorperazine maleate.    Indications: GI motil.disords., N&V of various caus., stimul.gastr.
   Indications: Mild/mod.ment./emot.disturbs. charact. by anx., tens.&   empty.dur.radiograph of stomach &/small intest., facilit.small   767123-026: 25 mg, 50, R273,21
                                                              Dosage: Take aft.meals.
   agitat., Ménière’s syndr., labyrinth., vertigo, migraine, N&V.  bowel intubat.
   (S5) TABS. J/2.6/184.        (S4) INJ, 34/5.7.2/0051. 10 mg/2 ml  Adults & childr.over 12 yrs:
                                                              Periph.circul.disords: 2-3 tabs 3xdly.
   744182-026: 5 mg, 250, R234,11  705973-001: 10x2 ml, R32,08  Bal.disords: 1 tab 3xdly. Max.dos: 9 tabs dly. If necess.div.dos.over
   Dosage: Anti-emetic: 1 -2 tabs 2 -3 xdly.  Dosage: Adults: 10-15 mg. IM/slow IV up to 4x dly. Consid.sngl.  2-3 intakes/day. Incr. progressive. as effs on vertigo is dos.depend.
   N & V: 4 tabs. Furth.dos.may be giv.if requir.  dos.of up to 20 mg where appropr.  Mot.sickn: Adults: 1 tab.2 hrs bef.journ., then ½-1 tab 8 hrly.dur.
   Migraine: 4 tabs at once follow.by 2 tabs 2hrs. later if necess.  Childr.15-19 yrs (30-59 kg): 5 mg 3x dly. ≥60 kg: 10 mg 3x dly.   journ.if reqd. Childr: 8-12 yrs: ½ tab. 3xdly.when reqd.
   Vertigo/Ménières dis: 3 -6 tabs in div.dos. Dos. may grad.be reduc.  9-14 yrs (≥30 kg): 5 mg 3x dly. 5-9 yrs (20-29 kg): 2,5 mg 3x dly.   Contraindications: Parkinsons.
   aft.sever.wks.to 1 -2  tabs.dly.  3-5 yrs (15-19 kg): 1 mg 2-3x dly. 1-3 yrs (10-14 kg): 0,5 mg 2-3x dly.   Side effects: Sedat., somnol., naus., weight incr., hypersomn.,
   Psychos: 2½tabs 2xdly for 7 days adjust.grad.to 75 -100 mg(15-  Where bm bel.spec.range admin.dos.accord.to bm rath.than age.   lethargy, stomach discomf., vomit., upper abdom.pain, dyspeps.,
   20 tabs) dly.accord.to respons. Maint: 5 -10  tabs dly.  Choose low.dos.  hyperhidros., fatig. Post market: Dyskines., extrapyramid. disords.,
   Non-psychot.anx.disords: 1 -2 tabs up to 3 -4  xdly.  Contraindications: GI condits.advers.affect.by musc.contract.  Parkinson., trem., cholestat.jaund., lichenoid keratos., lichen planus,
   Contraindications: Pre-exist.CNS depress./ coma/ bone-marr.  stimulat.eg.GI haemorrh./immed.aft. surg. phaeocromocyt., epilep.,   subacute cutan.lupus erythematos., musc.rigid.
   suppress./phaeochromocyt., childr.weigh.und.10 kg, safety in   concom.meds. induc. torsades de pointes/prolong.QT interv., safety   Warnings and special precautions: Safety in pregn. & lactat.
   pregn.& lactat. not est.     in pregn.& lactat.not est.    not est., concom.alcoh./CNS depress. or TCA’s, lact./fruct.intol.,
   Side effects: Sev.dyston.reacts.esp.in childr.& adolesc., dry mouth,   Side effects: Dyston.reacts.esp.in young femal., Parkinson., tard.  diab.mellit.
   GI disturbs., diffic.micturit., ocul. effs., CV/CNS effs., mios., EEG   dyskines.usual.in elderly dur. prolong. treatm., CNS effs., headache,   Interactions: Enhanc.sedat.eff.of CNS depress. incl.alcoh., eff.of
   chang., convuls., nas.congest., ejaculat.inhibit., impot., priapism,   galactorrh./ relat.disords., anx./agitat.esp.aft.rapid inj., ac. depress.,   atrop.& TCA’s poss. enhanc., MAOI may enhanc.antimuscar.effs.
   hypersens.reacts.incl.lupus-like syndr./ jaund./photosens., bld.dys-  bld.disords., hypersens.reacts., neurolept. malign.syndr., urin.incont.,
   cras.incl.fatal agranulocytos., extrapyramid.dysfunct., amenorh.,   GI disords., hypo/ hypertens., incr.plasma aldoster.conc.  TREVIGO, Novagen [P/S]
   galactorh., gynaecomast., mass gain, hyperglycaem., alter.gluc.tol.,   Special precautions: Childr./young pts., elderly, reg. review.with   Betahistine dihydrochlor.
   imp.body temp. regul., low.convuls.thresh.  prolong.ther., ren./hepat. impairm., fluid retent.risk, meds.caus. ex-  Indications: Vertigo assoc.with Ménière’s syndr.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page76.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page72.html">72</a>&nbsp;&nbsp;&nbsp;<a href="page73.html">73</a>&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>&nbsp;&nbsp;&nbsp;<a href="page75.html">75</a>&nbsp;&nbsp;&nbsp;<a href="page76.html">76</a>&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>&nbsp;&nbsp;&nbsp;<a href="page80.html">80</a>&nbsp;&nbsp;&nbsp;<a href="page81.html">81</a>&nbsp;&nbsp;&nbsp;<a href="page82.html">82</a>
             </td>
             <td width="35%"><a href="page78.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page78.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
